Safety assessment of nanomaterials using an advanced decision-making framework, the DF4nanoGrouping
Source abstract
Abstract
(DF4nanoGrouping) consisting of three tiers to assign nanomaterials to four main groups with possible further subgrouping to refine specific information needs. The DF4nanoGrouping covers all relevant aspects of a nanomaterial's life cycle and biological pathways: intrinsic material properties and system-dependent properties (that depend upon the nanomaterial's respective surroundings), biopersistence, uptake and biodistribution, and cellular and apical toxic effects. Use, release, and exposure route may be applied as 'qualifiers' to determine if, e.g., nanomaterials cannot be released from products, which may justify waiving of testing. The four main groups encompass (1) soluble, (2) biopersistent high aspect ratio, (3) passive, and (4) active nanomaterials. The DF4nanoGrouping foresees a stepwise evaluation of nanomaterial properties and effects with increasing biological complexity. In case studies covering carbonaceous nanomaterials, metal oxide, and metal sulfate nanomaterials, amorphous silica and organic pigments (all nanomaterials having primary particle sizes below 100 nm), the usefulness of the DF4nanoGrouping for nanomaterial hazard assessment was confirmed. The DF4nanoGrouping facilitates grouping and targeted testing of nanomaterials. It ensures that sufficient data for the risk assessment of a nanomaterial are available, and it fosters the use of non-animal methods. No studies are performed that do not provide crucial data. Thereby, the DF4nanoGrouping serves to save both animals and resources.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Recycling and Waste Management Techniques · Nanotechnology research and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Ann Rev Biomed Engineer 14:1–1610.1146/annurev-bioeng-071811-150124 ↗
2. Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Env Toxicol Chem 29:730–74110.1002/etc.34 ↗
3. Anzai T, Kaminishi M, Porth A, Handley J, Satoh T (2012) Worldwide trend in nanomaterial safety evaluation. Jpn J Env Toxicol 15:17–29
4. Arts JH, Muijser H, Duistermaat E, Junker K, Kuper CF (2007) Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months. Food Chem Toxicol 45:1856–186710.1016/j.fct.2007.04.001 ↗
5. Arts JH, Hadi M, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, Warheit D, Wiench K, Landsiedel R (2014) A critical appraisal of existing concepts for the grouping of nanomaterials. Regul Toxicol Pharmacol 70:492–50610.1016/j.yrtph.2014.07.025 ↗
6. Arts JH, Hadi M, Irfan MA, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, Warheit D, Wiench K, Wohlleben W, Landsiedel R (2015) A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). Regul Toxicol Pharmacol 71(Suppl 2):S1–S2710.1016/j.yrtph.2015.03.007 ↗
7. Arts JH, Irfan MA, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Neubauer N, Petry T, Sauer UG, Warheit D, Wiench K, Wohlleben W, Landsiedel R (2016) Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice. Regul Toxicol Pharmacol 76:234–26110.1016/j.yrtph.2015.11.020 ↗
8. Avramescu M-L, Rasmussen PE, Chénier M, Gardner HD (2016) Influence of pH, particle size and crystal form on dissolution behaviour of engineered nanomaterials. Env Sci Pollution Res. doi: 10.1007/s11356-016-7932-210.1007/s11356-016-7932-2 ↗
9. BAuA (2013) Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Bekanntmachung zu Gefahrstoffen. Hergestellte Nanomaterialien. – Federal Institute for Occupational Safety and Health. Announcement regarding hazardous substances. Manufactured nanomaterials. BekGS 527. BMBl 25:498–511
10. BAuA (2014) Bundesanstalt für Arbeitsschutz und Arbeitsmedizin. Begründung zum Allgemeinen Staubgrenzwert (2014/2001) in TRGS 900 „Arbeitsplatzgrenzwerte, Nr. 12 GMBl 2014, 271, Bek. d. BMAS v. 14.2.2014. IIIb 3, 35125–5. In: Bekanntmachung von Technischen Regeln – Federal Institute for Occupational Safety and Health. Justification of the general dust limit in the technical rule on hazardous substances 900 (occupational exposure limits Nr. 12), see: http://www.baua.de/cae/servlet/contentblob/664342/publicationFile/47939/900-allgemeiner- staubgrenzwert.pdf
11. BAuA (2015) Safe handling of nanomaterials and other advanced materials at workplace. NANOVALID–Developing reference methods for nanomaterials. Lead author and project monitoring: M. Baron, Federal Institute for Occupational Safety and Health
12. Becker H, Herzberg F, Schulte A, Kolossa-Gehring M (2011) The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int J Hyg Env Health 214:231–23810.1016/j.ijheh.2010.11.004 ↗
13. Bellmann B (2011) 14-day nose-only inhalation toxicity study of Z-COTE HP1 in Wistar WU rats. 02 G 09 005 (draft report). Fraunhofer ITEM, Germany. Study owner: Cefic, Belgium
14. Bos PM, Gottardo S, Scott-Fordsmand JJ, van Tongeren M, Semenzin E, Fernandes TF, Hristozov D, Hund-Rinke K, Hunt N, Irfan MA, Landsiedel R, Peijnenburg WJ, Sánchez Jiménez A, van Kesteren PC, Oomen AG (2015) The MARINA risk assessment strategy: a flexible strategy for efficient information collection and risk assessment of nanomaterials. Int J Env Res Public Health 12:15007–1502110.3390/ijerph121214961 ↗
15. Boverhof DR, Bramante CM, Butala JH, Clancy SF, Lafranconi M, West J, Gordon SC (2015) Comparative assessment of nanomaterial definitions and safety evaluation considerations. Regul Toxicol Pharmacol 73:137–15010.1016/j.yrtph.2015.06.001 ↗
16. Braakhuis HM, Oomen AG, Cassee FR (2016) Grouping nanomaterials to predict their potential to induce pulmonary inflammation. Toxicol Appl Pharmacol 299:3–710.1016/j.taap.2015.11.009 ↗
17. Bräu M, Ma-Hock L, Hesse C, Nicoleau L, Strauss V, Treumann S, Wiench K, Landsiedel R, Wohlleben W (2012) Nanostructured calcium silicate hydrate seeds accelerate concrete hardening: a combined assessment of benefits and risks. Arch Toxicol 86:1077–108710.1007/s00204-012-0839-x ↗
18. Buesen R, Landsiedel R, Sauer UG, Wohlleben W, Strauss V, Groeters S, Kamp HG, van Ravenzwaay B (2014) Effects of SiO2, ZrO2, and BaSO4 nanomaterials with or without surface functionalization upon 28-day oral exposure to rats. Arch Toxicol 88:1881–190610.1007/s00204-014-1337-0 ↗
19. Burden N, Aschberger K, Chaudhry Q, Dlift MJD, Doak SH, Fowler P, Johnston H, Landsiedel R, Rowland J, Stone V (2017) Aligning nanotoxicology with the 3Rs: what is needed to realise the short, medium and long-term opportunities? Nano Today, in press10.1016/j.yrtph.2017.10.021 ↗
20. Cassee FR, Kreyling W, Aitken R, Poland C (2015) Dosimetry and toxicology of nanosized particles and fibres. In: Viana M (ed.), Indoor and Outdoor Nanoparticles: Determinants of Release and Exposure Scenarios. Hdb Env Chem, DOI 10.1007/698_2015_415 , Springer, Switzerland10.1007/698_2015_415 ↗
21. Cho WS, Duffin R, Bradley M, Megson IL, MacNee W, Lee JK, Jeong J, Donaldson K (2013) Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles. Part Fibre Toxicol 10:5510.1186/1743-8977-10-55 ↗
22. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, Bawendi MG, Semmler-Behnke M, Frangioni JV, Tsuda A (2010) Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 28:1300–130310.1038/nbt.1696 ↗
23. Cohen JM, DeLoid GM, Demokritou P (2015) A critical review of in vitro dosimetry for engineered nanomaterials. Nanomed10.2217/nnm.15.129 ↗
24. Council of the EU (1998) Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical agents at work. OJ L 131/11-23, 5 May 1998
25. Dekkers S, Oomen AG, Bleeker EA, Vandebriel RJ, Micheletti C, Cabellos J, Janer G, Fuentes N, Vázquez-Campos S, Borges T, Silva MJ, Prina-Mello A, Movia D, Nesslany F, Ribeiro AR, Leite PE, Groenewold M, Cassee FR, Sips AJ, Dijkzeul A, van Teunenbroek T, Wijnhoven SW (2016) Towards a nanospecific approach for risk assessment. Regul Toxicol Pharmacol 80:46–5910.1016/j.yrtph.2016.05.037 ↗
26. DeLoid G, Cohen JM, Darrah T, Pyrgiotakis G, Wohlleben W, Demokritou P (2014) Estimating effective density of engineered nanomaterials for accurate in vitro dosimetry. ACS Nano 5:3514
27. DHHS (NIOSH) (2012) Department of Health and Human Services (National Institute for Occupational Safety and Health). General safe practices for working with engineered nanomaterials in research laboratories. Publication No. 2012-147
28. Ding Y, Kuhlbusch TA, Van Tongeren M, Jiménez AS, Tuinman I, Chen R, Alvarez IL, Mikolajczyk U, Nickel C, Meyer J, Kaminski H, Wohlleben W, Stahlmecke B, Clavaguera S, Riediker M (2017) Airborne engineered nanomaterials in the workplace—a review of release and worker exposure during nanomaterial production and handling processes. J Hazard Mater 322(Pt A):17–2810.1016/j.jhazmat.2016.04.075 ↗
29. Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ (2007) The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95:5–1210.1093/toxsci/kfl103 ↗
30. ECCC and HC (2016) Proposed prioritization approach for nanoscale forms of substances on the domestic substances list. Available at: http://www.ec.gc.ca/lcpe-cepa/default.asp?lang=En&n=FA3C8DBF-1 . Assessed: Feb 2017.
31. ECETOC (2013) European Centre for Ecotoxicology and Toxicology of Chemicals technical report 122. Poorly soluble particles. Lung overload, Brussels
32. ECHA (2012) European Chemicals Agency Guidance on information requirements and chemical safety assessment. Appendix R7-1 Recommendations for nanomaterials applicable to Chapter R7a endpoint specific guidance. ECHA-12-G-03-EN, Apr 2012
33. ECHA (2013) European Chemicals Agency Grouping of substances and read-across approach. Part I. Introductory note. ECHA-13-R-02-EN, Apr 2013
34. ECHA (2014) European Chemicals Agency Human health and environmental exposure assessment and risk characterization of nanomaterials. Best practice for REACH registrants. Third GAARN meeting—Helsinki, 30 Sep 2013. ECHA-14-R-10-EN, March 2014
35. ECHA (2017) European Chemicals Agency Read-Across Assessment Framework (RAAF) ECHA-17-R-01-EN, March 2017
36. EP and Council of the EU (2006) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ L 396/1, 30 Dec 2006
37. EP and Council of the EU (2010) Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. OJ L 276/33, 20 Oct 2010
38. EPA (2015) Environmental Protection Agency. Proposed rule—chemical substances when manufactured or processed as nanoscale materials; TSCA Reporting and Recordkeeping Requirements. FRL: 9920–90. Docket No. EPA-HQ-OPPT-2010-0572. Prepublication copy notice, 20 Mar 2015
39. EU Commission (2011) Commission recommendation 2011/696/EU on the definition of nanomaterial. OJ L 275:38, 18 Oct 2011
40. Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B (2008) Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82:151–15710.1007/s00204-007-0253-y ↗
41. Gebel T (2012) Small difference in carcinogenic potency between GBP nanomaterials and GBP micromaterials. Arch Toxicol 86:995–100710.1007/s00204-012-0835-1 ↗
42. Gebel T, Foth H, Damm G, Feyberger A, Kramer PJ, Lilienblum W, Röhl C, Schupp T, Weiss C, Wollin KM, Hengstler JG (2014) Manufactured nanomaterials: categorization and approaches to hazard assessment. Arch Toxicol 88:2191–221110.1007/s00204-014-1383-7 ↗
43. Godwin H, Nameth C, Avery D, Bergeson LL, Bernard D, Beryt E, Boyes W, Brown S, Clippinger AJ, Cohen Y, Doa M, Hendren CO, Holden P, Houck K, Kane AB, Klaessig F, Kodas T, Landsiedel R, Lynch I, Malloy T, Miller MB, Muller J, Oberdorster G, Petersen EJ, Pleus RC, Sayre P, Stone V, Sullivan KM, Tentschert J, Wallis P, Nel AE (2015) Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano 9:3409–341710.1021/acsnano.5b00941 ↗
44. Gosens I, Bokkers BGH, Zanella M, Manodori L, Hristozov D, de Jong WH, Stone V, Cassee FR (2015) Pulmonary effects of nano copper oxide in a short-term inhalation study (STIS). Poster No. 2348 at the 54th Annual Meeting and ToxExpo™ of the Society of Toxicology (SOT), San Diego CA, USA, 22–26 Mar 2015
45. Graham UM, Jacobs G, Yokel RA, Davis BH, Dozier AK, Birch ME, Tseng MT, Oberdösrter G, Elder A, DeLouise L (2017) From dose to response: in vivo nanoparticle processing and potential toxicity. Adv Exp Med Biol 947:71–10010.1007/978-3-319-47754-1_4 ↗
46. Greim H, Ziegler-Skylakakis K (2007) Risk assessment for biopersistent granular particles. Inhal Toxicol 19(Suppl 1):199–20410.1080/08958370701497689 ↗
47. Groeters S, Ernst H, Ma-Hock L, Strauss V, Landsiedel R, Wiench K, van Ravenzwaay B (2017) Long-term inhalation study with nano barium sulfate: unexpected morphological findings and lung-burden after 12 months of exposure. Poster at the 56th Annual Meeting and ToxExpo™ of the Society of Toxicology (SOT), Baltimore MD, USA, 12–16 March 2017
48. Hankin SM, Peters SAK, Poland CA, Foss Hansen S, Holmqvist J, Ross BL, Varet J, Aitken RJ (2011) Specific advice on fulfilling information requirements for nanomaterials under REACH (RIP-oN 2)—final project report. REACH-NANO consultation. RNC/RIP-oN2/FPR/1/FINAL
49. Heinrich U, Fuhst R, Rittinghausen S, Creutzenberg O, Bellmann B, Koch M, Levsen K (1995) Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal Toxicol 7:533–55610.3109/08958379509015211 ↗
50. Henderson RF, Driscoll KE, Harkema JR, Lindenschmidt RC, Chang IY, Maples KR, Barr EB (1995) A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats. Fundam Appl Toxicol 24:183–19710.1006/faat.1995.1022 ↗
51. Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden JG (2010) ISDD, a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol 7:3610.1186/1743-8977-7-36 ↗
52. Hofmann T, Schneider S, Wolterbeek A, van de Sandt H, Landsiedel R, van Ravenzwaay B (2015) Prenatal toxicity of synthetic amorphous silica nanomaterial in rats. Reprod Toxicol 56:141–14610.1016/j.reprotox.2015.04.006 ↗
53. Hofmann T, Ma-Hock L, Strauss V, Treumann S, Rey Moreno M, Neubauer N, Wohlleben W, Gröters S, Wiench K, Veith U, Teubner W, van Ravenzwaay B, Landsiedel R (2016) Comparative short-term inhalation toxicity of five organic diketopyrrolopyrrole pigments and two inorganic iron-oxide-based pigments. Inhal Toxicol 7:1–17
54. Hofmann T, Ma-Hock L, Athas J-C, Neubauer N, Wohlleben W, Gröters S, van Ravenzwaay B, Landsiedel R (2017) Contact angle of pigments predicts suffocation potential in acute inhalation toxicity tests in rats. Manuscript in preparation
55. Horev-Azaria L, Baldi G, Beno D, Bonacchi D, Golla-Schindler U, Kirkpatrick JC, Kolle S, Landsiedel R, Maimon O, Marche PN, Ponti J, Romano R, Rossi F, Sommer D, Uboldi C, Unger RE, Villiers C, Korenstein R (2013) Predictive toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of different cellular models using methods of knowledge discovery from data. Part Fibre Toxicol 10:3210.1186/1743-8977-10-32 ↗
56. Hristozov D, Zabeo A, Alstrup Jensen K, Gottardo S, Isigonis P, Maccalman L, Critto A, Marcomini A (2016) Demonstration of a modelling-based multi-criteria decision analysis procedure for prioritisation of occupational risks from manufactured nanomaterials. Nanotoxicol 29:1–14
57. IARC (2010a) International Agency for Research on Cancer. Monographs on the evaluation of carcinogenic risks to humans, IARC Lyon, France 93:166–171
58. IARC (2010b) International Agency for Research on Cancer. Carbon black: comparison of toxicokinetics and toxicodynamics of inhaled poorly soluble particles in animals and humans. In: World Health Organization, editor. IARC Monographs on the evaluation of carcinogenic risks to humans, Lyon, France, 93: 166–71: IARC
59. ISO (2014) International Standardization Organization. Technical specification. Nanotechnologies—occupational risk management applied to engineered nanomaterials—part 2: use of the control banding approach. ISO/TS 12901–2. 1st edition
60. Jahnel J (2015) Conceptual questions and challenges associated with the traditional risk assessment paradigm for nanomaterials. NanoEthics 9:261–27610.1007/s11569-015-0235-0 ↗
61. Kasai T, Umeda Y, Ohnishi M, Mine T, Kondo H, Takeuchi T, Matsumoto M, Fukushima S (2016) Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats. Part Fibre Toxicol 3:53
62. Keller J, Wohlleben W, Ma-Hock L, Groeters S, Küttler K, Strauss V, Wiench KE, Herden C, Oberdörster G, van Ravenzwaay B, Landsiedel R (2014) Time-course of lung retention and toxicity of inhaled particles: short-term exposure to nano-ceria. Arch Toxicol 88:2033–205910.1007/s00204-014-1349-9 ↗
63. Kettler K, Krystek P, Giannakou C, Hendriks AJ, de Jong WH (2016) Exploring the effect of silver nanoparticle size and medium composition on uptake into pulmonary epithelial 16HBE14o-cells. J Nanopart Res 18:18210.1007/s11051-016-3493-z ↗
64. Klein CL, Wiench K, Wiemann M, Ma-Hock L, van Ravenzwaay B, Landsiedel R (2012) Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 86(7):1137–115110.1007/s00204-012-0834-2 ↗
65. Kolle SN, Sauer UG, Rey-Moreno MC, Teubner W, Wohlleben W, Landsiedel R (2016) Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay. Part Fibre Toxicol 13:1810.1186/s12989-016-0128-6 ↗
66. Konduru N, Keller J, Ma-Hock L, Groeters S, Landsiedel R, Donaghey TC, Brain JD, Wohlleben W, Molina RM (2014) Biokinetics and effects of barium sulfate nanoparticles. Part Fibre Toxicol 11:5510.1186/s12989-014-0055-3 ↗
67. Krewski D, Andersen ME, Mantus E, Zeise L (2009) Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal 29:474–47910.1111/j.1539-6924.2008.01150.x ↗
68. Kroll A, Dierker C, Rommel C, Hahn D, Wohlleben W, Schulze-Isfort C, Göbbert C, Voetz M, Hardinghaus F, Schnekenburger J (2011) Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Part Fibre Toxicol 8:910.1186/1743-8977-8-9 ↗
69. Kuempel ED, Castranova V, Geraci CL, Schulte PA (2012) Development of risk-based nanomaterial groups for occupational exposure control. J Nanopart Res 14:102910.1007/s11051-012-1029-8 ↗
70. Kuempel ED, Attfield MD, Stayner LT, Castranova V (2014) Human and animal evidence supports lower occupational exposure limits for poorly-soluble respirable particles: letter to the editor re: ‘low-toxicity dusts: current exposure guidelines are not sufficiently protective’ by Cherrie, Brosseau, Hay and Donaldson. Ann Occup Hyg 8:1205–1208
71. Lai DY (2012) Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:1–1510.1002/wnan.162 ↗
72. Landsiedel R (2015) Concern-driven integrated approaches for the grouping, testing and assessment of nanomaterials. Env Pollut doi. doi: 10.1016/j.envpol.2015.10.06010.1016/j.envpol.2015.10.060 ↗
73. Landsiedel R, Kapp MD, Schulz M, Wiench K, Oesch F (2009) Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations—many questions, some answers. Mutat Res 681:241–25810.1016/j.mrrev.2008.10.002 ↗
74. Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, Wohlleben W (2010) Testing metal oxide nanomaterials for human safety. Adv Mater 22:2601–262710.1002/adma.200902658 ↗
75. Landsiedel R, Ma-Hock L, Haussmann HJ, van Ravenzwaay B, Kayser M, Wiench K (2012a) Inhalation studies for the safety assessment of nanomaterials: status quo and the way forward. Wiley Interdiscip Rev Nanomed Nanobiotechnol 4:399–41310.1002/wnan.1173 ↗
76. Landsiedel R, Fabian E, Ma-Hock L, Wohlleben W, Wiench K, Oesch F, van Ravenzwaay B (2012b) Toxico−/biokinetics of nanomaterials. Arch Toxicol 86:1021–106010.1007/s00204-012-0858-7 ↗
77. Landsiedel R, Ma-Hock L, Hofmann T, Wiemann M, Strauss V, Treumann S, Wohlleben W, Groeters S, Wiench K, van Ravenzwaay B (2014a) Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part Fibre Toxicol 11:1610.1186/1743-8977-11-16 ↗
78. Landsiedel R, Sauer UG, Ma-Hock L, Schnekenburger J, Wiemann M (2014b) Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays with in vivo inhalation or instillation studies. Nanomed 9:2557–258510.2217/nnm.14.149 ↗
79. Landsiedel R, Ma-Hock L, Keller J, Groeters S, Gebel T, Schaudien D, Laux P, Wiench K (2016) Long-term inhalation study with nanomaterials: effects and lung-burden after chronic inhalation study with ceria and barium sulfate. Abstract no. 43, 8th International Nanotoxicology Congress, Boston MA, USA, 1–4 June 2016
80. Lee KP, Trochimowicz HJ, Reinhardt CF (1985) Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for two years. Toxicol Appl Pharmacol 79:179–19210.1016/0041-008X(85)90339-4 ↗
81. Luoto K, Holopainen M, Karppinen K, Perander M, Savolainen K (1994) Dissolution of man-made vitreous fibers in rat alveolar macrophage culture and Gamble’s saline solution: influence of different media and chemical composition of the fibers. Env Health Perspect 102(Suppl 5):103–10710.1289/ehp.94102s5103 ↗
82. Lynch I, Weiss C, Valsami-Jones E (2014) A strategy for grouping of nanomaterials based on key physico-chemical descriptors as a basis for safer-by-design nanomaterials. Nano Today 9:266–27010.1016/j.nantod.2014.05.001 ↗
83. Ma-Hock L, Gamer AO, Landsiedel R, Leibold E, Frechen T, Sens B, Linsenbuehler M, van Ravenzwaay B (2007) Generation and characterization of test atmospheres with nanomaterials. Inhal Toxicol 19:833–84810.1080/08958370701479190 ↗
84. Ma-Hock L, Burkhardt S, Strauss V, Gamer AO, Wiench K, van Ravenzwaay B, Landsiedel R (2009a) Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. Inhal Toxicol 21:102–11810.1080/08958370802361057 ↗
85. Ma-Hock L, Treumann S, Strauss V, Brill S, Luizi F, Mertler M, Wiench K, Gamer AO, van Ravenzwaay B, Landsiedel R (2009b) Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol Sci 112:468–48110.1093/toxsci/kfp146 ↗
86. Ma-Hock L, Landsiedel R, Wiench K, Geiger D, Strauss V, Gröters S, van Ravenzwaay B, Gerst M, Wohlleben W, Scherer G (2012) Short-term rat inhalation study with aerosols of acrylic ester-based polymer dispersions containing a fraction of nanoparticles. Int J Toxicol 31:46–5710.1177/1091581811424778 ↗
87. Ma-Hock L, Strauss V, Treumann S, Kuttler K, Wohlleben W, Hofmann T, Groeters S, Wiench K, van Ravenzwaay B, Landsiedel R (2013) Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol 10:2310.1186/1743-8977-10-23 ↗
88. Ma-Hock L, Ernst H, Keller J, Groeters S, Landsiedel R, van Ravenzwaay B, Schaudien D, Rittinghausen S (2016) Histopathological findings after 12 months inhalation to nano ceria. Abstract no. 2537. 55th Annual Meeting and ToxExpo™ of the Society of Toxicology (SOT), New Orleans LA, USA 13–17 March 2016
89. MAK (2013) Commission for the investigation of health hazards of chemical compounds in the work area. Nanomaterials—report. Deutsche Forschungsgemeinschaft–German Research Foundation (ed.). ISBN 978-3-527-33571-8. Wiley-VCH, Weinheim, Germany
90. Maser E, Schulz M, Sauer UG, Wiemann M, Ma-Hock M, Wohlleben W, Hartwig A, Landsiedel R (2015) In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials. Mut Res 794:57–7410.1016/j.mrgentox.2015.10.005 ↗
91. Monteiro-Riviere NA, Inman AO, Zhang LW (2009) Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–23510.1016/j.taap.2008.09.030 ↗
92. Monteiro-Riviere NA, Wiench K, Landsiedel R, Schulte S, Inman AO, Riviere JE (2011) Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study. Tox Sci 123:264–28010.1093/toxsci/kfr148 ↗
93. Moreno-Horn M, Gebel T (2014) Granular biodurable nanomaterials: no convincing evidence for systemic toxicity. Crit Rev Toxicol 44:849–87510.3109/10408444.2014.938802 ↗
94. Morfeld P, Treumann S, Ma-Hock L, Bruch J, Landsiedel R (2012) Deposition behavior of inhaled nanostructured TiO2 in rats: fractions of particle diameter below 100 nm (nanoscale) and the slicing bias of transmission electron microscopy. Inhal Toxicol 24:939–951 erratum in: Inhal Toxicol 25:307, 201310.3109/08958378.2012.738256 ↗
95. Morfeld P, Bruch J, Levy L, Ngiewih Y, Chaudhuri I, Muranko HJ, Myerson R, McCunney RJ (2015) Translational toxicology in setting occupational exposure limits for dusts and hazard classification—a critical evaluation of a recent approach to translate dust overload findings from rats to humans. Part Fibre Toxicol 12:310.1186/s12989-015-0079-3 ↗
96. Morimoto Y, Izumi H, Yoshiura Y, Tomonaga T, Lee BW, Okada T, Oyabu T, Myojo T, Kawai K, Yatera K, Shimada M, Kubo M, Yamamoto K, Kitajima S, Kuroda E, Horie M, Kawaguchi K, Sasaki T (2015) Comparison of pulmonary inflammatory responses following intratracheal instillation and inhalation of nanoparticles. Nanotoxicol 11:1–12
97. Morrow PE (1988) Possible mechanisms to explain dust overloading of the lungs. Fund Appl Toxicol 10:369–38410.1016/0272-0590(88)90284-9 ↗
98. Morrow PE (1994) Mechanisms and significance of “particle overload”. In: Toxic and carcinogenic effects of solid particles in the respiratory tract: Proceedings of the 4th International Inhalation Symposium, March 1993; Hannover, Germany. International Life Sciences Institute Press, Washington DC, USA, 17–25
99. Morrow PE, Haseman JK, Hobbs CH, Driscoll KE, Vu V, Oberdörster G (1996) The maximum tolerated dose for inhalation bioassays: toxicity vs. overload. Fundam Appl Toxicol 29:155–16710.1006/faat.1996.0017 ↗
100. Nel AE, Xia T, Meng H, Wang X, Lin S, Ji Z, Zhang H (2013) Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res 46:607–62110.1021/ar300022h ↗